GLENN KAZO

Company: ARIZ

Job title: CBO

Seminars:

Using RNAi to Identify & Validate Novel Targets for Cancer Drug Development 11:30 am

• RNAi knockdown is a key step in determining the best modality for drug development • Selected Oncology targets may not require complete knockdown! • Explore examples from the Histone methyltransferase family  Read more

day: Conference Day One